Cargando…

Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study

Background: Biologics are used to treat moderate-to-severe psoriasis, and persistence to biologics may reflect clinical effectiveness. Limited information describing how biologics are used in patients with moderate-to-severe psoriasis in Asian countries is available. We conducted a population-based,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yu-Huei, Tang, Chao-Hsiun, Goh, Choo Hua, Chang, Chia-Li, Qiu, Hong, Yang, Ya-Wen, Saadoun, Carine, Chang, Chia-Ling, Liu, Yanfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152324/ https://www.ncbi.nlm.nih.gov/pubmed/35656306 http://dx.doi.org/10.3389/fphar.2022.880985

Ejemplares similares

Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
por: Li, Ko-Jen, et al.
Publicado: (2021)

Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan
por: Chen, Der-Yuan, et al.
Publicado: (2019)

Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2022)

Treatment adherence among new triptan users: a 2-year cohort study in Taiwan
por: Chen, Ting-Bin, et al.
Publicado: (2014)

Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
por: Cai, Jiangluyi, et al.
Publicado: (2021)

Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan
por: Chen, Yu-Chen, et al.
Publicado: (2020)

A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan
por: Hou, Hsin-An, et al.
Publicado: (2022)

Editorial: The polysaccharides from marine organisms and fungi: Biological functions and molecular mechanisms
por: Pereira, Leonel, et al.
Publicado: (2022)

Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2021)

Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2
por: Kim, Byung Soo, et al.
Publicado: (2023)

Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules
por: He, Huan, et al.
Publicado: (2021)

Treatment evolution and improved survival in multiple myeloma in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan
por: Chao, En, et al.
Publicado: (2020)

Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
por: Di Lernia, Vito, et al.
Publicado: (2022)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

Correction to: Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan
por: Chao, En, et al.
Publicado: (2021)

Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2020)

Gynura procumbens: An Overview of the Biological Activities
por: Tan, Hui-Li, et al.
Publicado: (2016)

Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil
por: Silveira, Miriam Sanches do Nascimento, et al.
Publicado: (2014)

Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan
por: Okubo, Yukari, et al.
Publicado: (2021)

Biological Activities of Snowdrop (Galanthus spp., Family Amaryllidaceae)
por: Kong, Chee Kei, et al.
Publicado: (2021)

Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2021)

Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan
por: Chen, Teng-Chou, et al.
Publicado: (2013)

Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
por: Wang, Yi-Jen, et al.
Publicado: (2018)

Ethnobotanical Survey of Natural Galactagogues Prescribed in Traditional Chinese Medicine Pharmacies in Taiwan
por: Chao, Jung, et al.
Publicado: (2021)

Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
por: Nieto-González, Juan Carlos, et al.
Publicado: (2021)

Systems biology reveals anatabine to be an NRF2 activator
por: Messinis, Dimitris E., et al.
Publicado: (2022)

Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan(®) Databases
por: Leonardi, Craig, et al.
Publicado: (2022)

Economic Burden of Atopic Dermatitis in Taiwan
por: LEE, Ellen M., et al.
Publicado: (2023)

Timing, Dosage, and Adherence of Antiretroviral Therapy and Risk of Osteoporosis in Patients With Human Immunodeficiency Virus Infection in Taiwan: A Nested Case-Control Study
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan
por: CHAN, Tom C., et al.
Publicado: (2021)

Biologically Targeted Magnetic Hyperthermia: Potential and Limitations
por: Chang, David, et al.
Publicado: (2018)

Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis
por: Li, Yunfeng, et al.
Publicado: (2014)

Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management
por: Kelly, Katherine A., et al.
Publicado: (2021)

Angelicin—A Furocoumarin Compound With Vast Biological Potential
por: Mahendra, Camille Keisha, et al.
Publicado: (2020)

BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010)

Biologics in the management of psoriasis
por: Bahner, Jennifer D, et al.
Publicado: (2009)

Biologics and Biosimilars in Psoriasis
por: Ahmed, Sk Shahriar, et al.
Publicado: (2023)

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
por: Schmitt-Egenolf, Marcus, et al.
Publicado: (2021)

Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions
por: Tang, Jinxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jrhidbuaseohdnhvf88crca3di